This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Tel Aviv University, Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Inbar Elron-Gross: Innovator in Nanotechnology for Medical Applications
Introduction
Inbar Elron-Gross is a notable inventor based in Ramat Hasharon, Israel. He has made significant contributions to the field of nanotechnology, particularly in the development of iron oxide nanoparticles for medical applications. His work focuses on innovative solutions for treating non-infectious inflammatory disorders.
Latest Patents
Inbar Elron-Gross holds a patent for "Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders." This patent outlines the use of iron oxide nanoparticles in the treatment of such disorders, along with methods of treatment, pharmaceutical compositions, and kits that incorporate these particles. He has 1 patent to his name, showcasing his commitment to advancing medical technology.
Career Highlights
Throughout his career, Inbar has worked with prestigious institutions, including Tel Aviv University and Tel Hashomer Medical Research Infrastructure and Services Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Inbar has collaborated with notable colleagues, including Rimona Margalit and Yifat Glucksam-Galnoy. Their combined expertise has fostered an environment of innovation and discovery in the realm of nanotechnology and medical applications.
Conclusion
Inbar Elron-Gross is a pioneering inventor whose work in iron oxide nanoparticles is paving the way for new treatments for non-infectious inflammatory disorders. His contributions to the field of nanotechnology are significant and hold promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile